Prevnar 13, cover 13种肺炎链球菌;大人打的是23价
Prevnar 13 is produced by Pfizer. It is a triskaivalent vaccine, meaning that it contains thirteen serotypes of pneumococcus (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) which are conjugated to a carrier protein. Prevnar 13 was approved by the U.S. Food and Drug Administration for immediate release to the public on February 24, 2010. It is to be given on the same schedule as was Prevnar
http://en.wikipedia.org/wiki/Pneumococcal_conjugate_vaccine